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Abstract: Antimicrobial and biocide resistance is a major public health problem today. Therefore, 
one of the main scientific challenges nowadays is the search for alternatives to these substances. One 
of these potential alternatives are the bacteriocins. Microbiota are a potential source of bacteriocin-
producing bacteria that need to be studied. In this study, a total of 40 samples of human milk and 
10 samples of cow milk were collected from healthy individuals and stored at −20 °C until use. 
Colonies isolated from these samples that showed antimicrobial activity against Lactobacillus del-
brueckii ssp. bulgaricus in the overlaid assays were selected. Well diffusion assays were carried out 
with the cell-free supernatant (CFS) from these colonies neutralized to pH and inhibition zones were 
recorded. The activity against eight common bacterial pathogens was evaluated. A total of 32 colo-
nies with potential antimicrobial activity were isolated. The neutralized CFS of 10 strains showed 
antimicrobial activity against at least one pathogen tested in the well diffusion assays. Eight of the 
10 CFS inhibited the growth of Staphylococcus aureus. These CFS also showed activity against Staph-
ylococcus epidermidis, Streptococcus agalactiae, Pseudomonas aeruginosa , L. monocytogenes, Clostridium 
perfringens and Clostridioides difficile. The next steps of the research will be 16s rRNA sequencing to 
identify the species of isolates and mass spectrometry to determine the antimicrobial product pro-
duced by isolation. Finally, this study demonstrated that milk microbiota are a potential source of 
new producing bacteriocin bacteria that can be used in the formulation of new food products. 
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1. Introduction 
The discovery and use of antibiotics were a major advance in human health. Bacterial 
infections that could end in death began to be easily treated with these substances. Anti-
biotics also revolutionized animal production [1,2]. These substances are used to treat an-
imal infections, but also were and still are used in some countries as growth promoters 
[3]. Indiscriminate use of antibiotics resulted in the spread of antimicrobial resistance. 
Thus, at present, there is a global problem due to the appearance of multi-resistance in 
pathogenic bacteria [4]. This has resulted in a significant increase in the number of deaths 
associated with multi-resistant bacteria. In the field of food science, there is also increasing 
concern among consumers about the use of synthetic preservatives in food, as some of 
them, such as sulfites and nitrites, have been linked to possible adverse effects on human 
health [5,6]. There has also been an increase in the resistance of food pathogens to biocides 
commonly used in the food industry [7]. Therefore, one of the main challenges of actual 
society is the search for alternative substances to antibiotics and preservatives. In the last 
years, microbiota from different sources have emerged as a potential source of natural 
substances with antimicrobial activity [8]. Many of the bacteria present in the microbiota 
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synthesize bacteriocins, ribosomally produced antimicrobial peptides synthesized by 
both Gram-positive and Gram-negative bacteria with activity against closely related bac-
teria (narrow spectrum) or a diverse group of bacteria (broad spectrum) [9]. Although 
some bacteriocins such as nisin are already known, there is still a large number to be dis-
covered and evaluated. The aim of this study was to isolate bacteria with antimicrobial 
activity from the microbiota of breast milk and cow milk. 
2. Material and Methods 
A total of 40 samples were included in this study for the isolation of strains with po-
tential antimicrobial activity against different common pathogens. From these, 30 milk sam-
ples were collected aseptically from healthy women at different breastfeeding stages. The 
other 10 samples were collected individually from different dairy cows. After collection, 
samples were kept at −20 °C until use. 
The isolation of strains with potential antimicrobial activity was carried out using an 
overlaid method with Lactobacillus delbrueckii ssp. bulgaricus. Briefly, a volume of 1 mL of 
milk was serially diluted in maximum recovery diluent (MRD)(0.85% NaCL and 0.01% 
Tryptone) until a final dilution of 10−4. A volume of 100 μL of the initial sample and dilutions 
were then spread in different plate agar media. The agar media included in this study were 
Brain heart infusion (BHI)(Merck Millipore, Darmstadt, Germany) agar and Columbia agar 
(Merck Millipore). The BHI plates were incubated at 37 °C for 48 h aerobically and Columbia 
agar plates were incubated 72 h at 37 °C anaerobically using GENbox atmosphere genera-
tors (bioMérieux, Craponne, France) and anaerobic jars. After incubation, plates that 
showed separated colonies were overlaid with Man Rogosa Sharpe (MRS)(Merck Millipore) 
containing 0.75% agar seeded with 0.25% of an overnight culture of Lactobacillus delbrueckii 
ssp. bulgaricus LMG 6901 in MRS broth. The plates were then incubated anaerobically for 24 
h at 37 °C. After incubation, the colonies that showed inhibition zones of the indicator L. 
delbrueckii ssp. bulgaricus LMG 6901 were picked and streaked in BHI agar and incubated 
for 24 h at 37 °C to obtain pure colonies. Finally, a pure colony was picked and transferred 
to BHI broth and incubated 24 h at 37 °C. Each strain was stocked in 20% glycerol and stored 
at −20 °C for further characterization. 
The characterization of the antimicrobial activity of the strains was determined using 
the well diffusion assay (WDA). Briefly, milk isolated strains were grown in 50 mL polysty-
rene filled with 20 mL of BHI medium for 48 h at 37 °C. After incubation, the growth media 
were centrifuged at 5000× g for 15 min. The cell free supernatant (CFS) was collected and 
filtered using 0.22 μm syringe filters and saved at −20 °C until use. To eliminate inhibition 
due to acids produced during bacterial growth, the pH of the CFS was determined and neu-
tralized to pH 7.0–7.2 using 2M NaOH. The antimicrobial activity of CFS was determined 
against 8 different indicator bacteria (Staphylococcus epidermidis CECT 59, Staphylococcus au-
reus CECT 231, Salmonella typhimurium CECT 4594, Streptococcus agalactiae CECT 183T, Pseu-
domonas aeruginosa CECT 108, Listeria monocytogenes CECT 934, Clostridium perfringens CECT 
376T and Clostridioides difficile CECT 531T). These strains were grown in BHI for 24 h at 37 
°C aerobically, with the exception of C. difficile CECT 531T and C. perfringens CECT 376T, 
which were grown anaerobically in Reinforced Clostridial Medium (RCM)(VWR, Spain) or 
24 h at 37 °C. BHI media with 0.75% agar was seeded with 0.25% of indicator bacteria and 
20 mL were transferred to agar plates. For C. difficile CECT 531T and C. perfringens CECT 
376T, RCM was used instead of BHI. After the agar solidified, 5 mm diameter holes were 
made and filled with 75 μL of the milk isolated strain WDAs. The plates were incubated for 
24 h at 37 °C and the inhibition zones were measured. 
3. Results 
A total of 32 colonies with potential antimicrobial activity according the overlaid re-
sult with L. delbrueckii ssp. bulgaricus LMG 6901 were isolated. From these, 28 colonies 
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were isolated from breast milk and four colonies were isolated from cow milk. The neu-
tralized CFS of 10 strains showed antimicrobial activity against at least one pathogen 
tested in the well diffusion assays. Seven strains were isolated from breast milk and three 
strains were isolated from cow milk. Eight of the 10 CFS inhibited the growth of S. aureus. 
These CFS also showed activity against S. epidermidis, S. agalactiae, P. aeruginosa, L. mono-
cytogenes, and C. perfringens and one strain against C. difficile (Figure 1). 
 
Figure 1. Well diffusion assays of Clostridium perfringens and Clostridioides difficile with two strains 
isolated from milk showing antimicrobial activity. 
The inhibition potential of each strain was calculated as the area of the zone πr2—the 
area of the well πr2 in millimeters (Table 1). Although 8 of the 10 strains isolated inhibited 
the growth of Staphylococcus aureus, only two strains showed strong inhibition. 
Table 1. Spectrum of inhibition of bacteriocin-producing milk isolates against indicator strains according to well diffusion 
assays. -, no inhibition; +, <50 mm2; ++, 50–150 mm2; +++, 150–249 mm2; ++++, 150–249 mm2. 
Indicator/Strain LM18.1 LM16.1 LM61 LM95 LM27 LM12 LM88 L3.1 L3.2 L6.10 
Staphylococcus epidermidis CECT 59 - - - + -   -   
Staphylococcus aureus CECT 231 - - + + + +++ + ++++ + + 
Streptococcus agalactiae CECT 183T + ++ ++++    +++ - - - 
Listeria monocytogenes CECT 934 - - - - - - - +++ - - 
Clostridium perfringens CECT 376T - - + - - - - - - - 
Clostridioides difficile CECT 531T ++ +++ - - - - - - +++ ++++ 
Salmonella typhimurium CECT 4594 - - - - - - - - - - 
Pseudomonas aeruginosa CECT 108 - - - - - - - + - - 
It is also interesting that four of the seven strains isolated from breast milk inhibited 
the growth of Streptococcus agalactiae CECT 183T. Especially, LM61 showed strong inhibi-
tion activity. Two strains of breast milk and two strains of cow milk also inhibited the 
growth of Clostridioides difficile CECT 531T, and L6.10 showed strong inhibition activity. 
Breast milk and cow milk microbiota are a source of antimicrobial-producing bacteria. In 
the next steps of the work, the strains isolated from breast milk and cow milk will be iden-
tified by 16s rRNA sequencing and mass spectrometry will be used to determine the anti-
microbial product produced by isolation. 
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